v3.26.1
REVISIONS TO PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details Narrative) - USD ($)
 3 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Jan. 01, 2025
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Retained earnings $ (238,252,234) $ (228,603,075)  
Description of prior-period information adjusted (1) a $1.0 million understatement of an insurance receivable and corresponding liability related to a pending legal matter previously recorded on a net basis, (2) a $1.0 million, $1.0 million and $1.5 million understatement of accounts receivable and corresponding liability related to deferred costs associated with one of the Company’s net revenue arrangements with a third-party pharmacy provider as of December 31, 2024, March 31, 2025 and June 30, 2025, respectively, (3) $1.5 million in voluntary disclosure sales tax expense that was overstated for the year ended December 31, 2024 and understated by $1.5 million for the years ended December 31, 2023, 2022 and 2021 for the Company’s WorkSimpli business and (4) $0.5 million in WorkSimpli distributions that understated non-controlling interest during the three months ended December 31, 2024 and overstated non-controlling interest for the first and second quarters of 2024.    
Revision of Prior Period, Adjustment [Member]      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Retained earnings     $ 3,600,000